Restart Life Sciences Corp (HEAL.CX)
0.025
-0.02
(-37.50%)
CAD |
CNSX |
Nov 13, 14:48
Restart Life Sciences Enterprise Value: 1.234M for Nov. 12, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2024 | 1.234M |
| November 11, 2024 | 1.234M |
| November 08, 2024 | 1.234M |
| November 07, 2024 | 0.7895M |
| November 06, 2024 | 0.7895M |
| November 05, 2024 | 0.7895M |
| November 04, 2024 | 0.7895M |
| November 01, 2024 | 0.7895M |
| October 31, 2024 | 0.7895M |
| October 30, 2024 | 0.7895M |
| October 29, 2024 | 0.7895M |
| October 28, 2024 | 0.7895M |
| October 25, 2024 | 0.7895M |
| October 24, 2024 | 0.7895M |
| October 23, 2024 | 0.7895M |
| October 22, 2024 | 0.7895M |
| October 21, 2024 | 0.7895M |
| October 18, 2024 | 0.7895M |
| October 17, 2024 | 0.7895M |
| October 16, 2024 | 0.7895M |
| October 15, 2024 | 0.7895M |
| October 11, 2024 | 1.531M |
| October 10, 2024 | 1.531M |
| October 09, 2024 | 1.531M |
| October 08, 2024 | 1.531M |
| Date | Value |
|---|---|
| October 07, 2024 | 0.7895M |
| October 04, 2024 | 0.7895M |
| October 03, 2024 | 0.7895M |
| October 02, 2024 | 0.7895M |
| October 01, 2024 | 0.7895M |
| September 30, 2024 | 0.7895M |
| September 27, 2024 | 0.7895M |
| September 26, 2024 | 0.7895M |
| September 25, 2024 | 0.7895M |
| September 24, 2024 | 0.7895M |
| September 23, 2024 | 0.7895M |
| September 20, 2024 | 0.7895M |
| September 19, 2024 | 0.7895M |
| September 18, 2024 | 0.7895M |
| September 17, 2024 | 0.7895M |
| September 16, 2024 | 0.7895M |
| September 13, 2024 | 0.7895M |
| September 12, 2024 | 0.7895M |
| September 11, 2024 | 0.7895M |
| September 10, 2024 | 0.7895M |
| September 09, 2024 | 0.7895M |
| September 06, 2024 | 0.7895M |
| September 05, 2024 | 0.7895M |
| September 04, 2024 | 1.531M |
| September 03, 2024 | 1.531M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.7895M
Minimum
Sep 05 2024
31.20M
Maximum
Jan 07 2021
7.228M
Average
6.482M
Median
Jul 11 2022
Enterprise Value Benchmarks
| Biocure Technology Inc | 0.4866M |
| Core One Labs Inc | -- |
| Nanosphere Health Sciences Inc | 0.3707M |
| Lobe Sciences Ltd | 4.758M |
| Algernon Pharmaceuticals Inc | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.0906M |
| Total Expenses (Quarterly) | 0.0908M |
| EPS Diluted (Quarterly) | -0.0031 |
| Earnings Yield | -97.92% |
| Normalized Earnings Yield | -232.46 |